Please login to the form below

Not currently logged in
Email:
Password:

The Medicines Company appoints Biogen's Tony Kingsley

He will be the New Jersey firm's president and COO

The Medicines Company Tony KingsleyBiogen's Tony Kingsley has moved to The Medicines Company to take up the role of chief operating officer, where he will help oversee the New Jersey firm's day-to-day operations and lead its commercial activities.

He will also serve at the company, which focuses on serious infectious disease care, acute cardiovascular care, and surgery and perioperative care, as its president, taking over from Glenn Sblendorio, who retired in January.

Clive Meanwell, chief executive officer of The Medicines Company, said: “Tony brings extensive leadership experience and broad operational expertise developed over a long and enormously successful career. 

“His contributions will be invaluable as the company enters this exciting period and we continue to execute on our strategy to drive growth from our core, high-value assets, while maximising strategic and operational flexibility.”

Kingsley previously served as Biogen's executive vice president, global commercial operations, where the product launches he oversaw included the multiple sclerosis blockbuster Tecfidera (dimethyl fumerate).

Prior to that he spent time at Hologic as general manager of its gynaecological surgical products business and at Cytyc Corporation as president of its diagnostic products division.

Kingsley also previously worked as a partner at McKinsey & Company focusing on the biotechnology, pharmaceutical and medical device industries.

He said: “This is an extraordinary opportunity to be part of a company that carries the promise of profoundly improving and extending the lives of so many, while fundamentally altering the competitive landscape.”

26th May 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...

Infographics